Delivery Order SPE2DB20D2014-SPE2DB25FB67G

Award Date 4/17/25
Potential Completion Date 4/18/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,641.63, is for the delivery of the drug Loryna 3 mg-0.02 mg tablet in quantities of 28 tablets. The contract is a Firm Fixed Price Delivery Order, with a completion date of November 27, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,030.79, is a delivery order for the medication "LORYNA 3-0.02MG 84S". The contract is a firm fixed-price, non-set-aside award with a performance period through June 2, 2025. Amerisourcebergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $1,003.20, is a firm fixed-price delivery order for the pharmaceutical product LORYNA 3 MG-0.02 MG TABLET 28S. The contract has an ultimate completion date of November 7, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that provides a comprehensive range of medical products to federal agencies, particularly within...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $1,853.51, is for the delivery of Loryna 3 mg-0.02 mg tablets to support federal healthcare programs. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,101.41 firm fixed-price delivery order is for the supply of the prescription medication Loryna 3 mg-0.02 mg tablets. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,327.36, is for the delivery of the prescription medication Loryna 3 mg-0.02 mg tablets. This is a firm fixed-price delivery order contract with an ultimate completion date of August 12, 2024. Amerisourcebergen holds a larger indefinite delivery contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp's Corporate Office Division. The $1,597.98 firm fixed price delivery order is for the supply of the pharmaceutical product LORYNA 3 MG-0.02 MG TABLET 28S. This contract is not designated as a set-aside. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,616.67 Firm Fixed Price Delivery Order contract is for the supply of the generic drug Loryna 3 mg-0.02 mg tablet, 28 count. The contract has a completion date of September 12, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,133.10, is for the delivery of the pharmaceutical product LORYNA 3 MG-0.02 MG TABLET 28S. This is a firm fixed-price delivery order contract with a completion date of November 16, 2023. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,370.72 firm fixed-price delivery order contract is for the supply of LORYNA 3 MG-0.02 MG TABLET 28S, a pharmaceutical product. The contract has an ultimate completion date of November 27, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FB67G
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,378.00, is a delivery order for the medication Loryna 3 mg-0.02 mg tablet 28s. The contract is a firm fixed-price arrangement without any set-aside designation, indicating open competition.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This prime contract, designated as SPE2DX, provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. The IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 7/17/25, 2:40 PM